Zum Inhalt

Journal of Cancer Research and Clinical Oncology

Ausgabe 1/2020

Inhalt (24 Artikel)

Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia

  • Review – Cancer Research

Devarajan Nalini, Jayaraman Selvaraj, Ganesan Senthil Kumar

Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance

  • Review – Cancer Research

Masoud Najafi, Bagher Farhood, Keywan Mortezaee, Ebrahim Kharazinejad, Jamal Majidpoor, Reza Ahadi

Incorporation of Astragalus polysaccharides injection during concurrent chemoradiotherapy in advanced pharyngeal or laryngeal squamous cell carcinoma: preliminary experience of a phase II double-blind, randomized trial

  • Original Article – Cancer Research

Chia-Hsun Hsieh, Chien-Yu Lin, Cheng-Lung Hsu, Kang-Hsing Fan, Shiang-Fu Huang, Chun-Ta Liao, Li-Yu Lee, Shu-Kung Ng, Tzu-Chen Yen, Joseph Tung-Chieh Chang, Jr-Rung Lin, Hung-Ming Wang

The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients

  • Original Article – Cancer Research

Bing-Yen Wang, Jing-Yang Huang, Heng-Chung Chen, Ching-Hsiung Lin, Sheng-Hao Lin, Wei-Heng Hung, Ya-Fu Cheng

Sexual dimorphism in gastric cancer: tumor-associated neutrophils predict patient outcome only for women

  • Open Access
  • Original Article – Cancer Research

Franziska Clausen, Hans-Michael Behrens, Sandra Krüger, Christoph Röcken

Marital status independently predicts non-small cell lung cancer survival: a propensity-adjusted SEER database analysis

  • Original Article – Cancer Research

Zongwei Chen, Kanhua Yin, Difan Zheng, Jie Gu, Jizhuang Luo, Shuai Wang, Haiquan Chen

High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1

  • Open Access
  • Original Article – Cancer Research

Yukio Maezawa, Kentaro Sakamaki, Naohide Oue, Yayoi Kimura, Itaru Hashimoto, Kentaro Hara, Kazuki Kano, Toru Aoyama, Yukihiko Hiroshima, Takanobu Yamada, Naoto Yamamoto, Takashi Ogata, Hiroyuki Ito, Haruhiko Cho, Manabu Shiozawa, Takaki Yoshikawa, Soichiro Morinaga, Yasushi Rino, Wataru Yasui, Munetaka Masuda, Yohei Miyagi, Takashi Oshima

Candidate lncRNA–miRNA–mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis

  • Original Article – Cancer Research

Rui Zhang, Ying-yi Jiang, Kun Xiao, Xiao-quan Huang, Jian Wang, Shi-yao Chen

DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics

  • Original Article – Cancer Research

Felix K. F. Kommoss, Damian Stichel, Daniel Schrimpf, Mark Kriegsmann, Basile Tessier-Cloutier, Aline Talhouk, Jessica N. McAlpine, Kenneth T. E. Chang, Dominik Sturm, Stefan M. Pfister, Laura Romero-Pérez, Thomas Kirchner, Thomas G. P. Grünewald, Rolf Buslei, Hans-Peter Sinn, Gunhild Mechtersheimer, Peter Schirmacher, Dietmar Schmidt, Hans-Anton Lehr, Felix Sahm, David G. Huntsman, C. Blake Gilks, Friedrich Kommoss, Andreas von Deimling, Christian Koelsche

High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer

  • Original Article – Cancer Research

Dong Won Baek, Gyeonghwa Kim, Byung Woog Kang, Hye Jin Kim, Su Yeon Park, Jun Seok Park, Gyu-Seog Choi, Min Kyu Kang, Keun Hur, Jong Gwang Kim

Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells

  • Original Article – Cancer Research

Moiken Mehner, Carolin Kubelt, Vivian Adamski, Christina Schmitt, Michael Synowitz, Janka Held-Feindt

High density of CD66b in primary high-grade ovarian cancer independently predicts response to chemotherapy

  • Original Article – Cancer Research

Alberto Posabella, Philipp Köhn, Alexandros Lalos, Alexander Wilhelm, Robert Mechera, Savas Soysal, Simone Muenst, Uwe Güth, Sylvia Stadlmann, Luigi Terracciano, Raoul A. Droeser, Jasmin Zeindler, Gad Singer

Evolving the pulmonary nodules diagnosis from classical approaches to deep learning-aided decision support: three decades’ development course and future prospect

  • Review – Clinical Oncology

Bo Liu, Wenhao Chi, Xinran Li, Peng Li, Wenhua Liang, Haiping Liu, Wei Wang, Jianxing He

The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma

  • Original Article – Clinical Oncology

Ho Won Kang, Sung Min Kim, Won Tae Kim, Seok Joong Yun, Sang-Cheol Lee, Wun-Jae Kim, Eu Chang Hwang, Seok Ho Kang, Sung-Hoo Hong, Jinsoo Chung, Tae Gyun Kwon, Hyeon Hoe Kim, Cheol Kwak, Seok-Soo Byun, Yong-June Kim

Microwave ablation as local consolidative therapy for patients with extracranial oligometastatic EGFR-mutant non-small cell lung cancer without progression after first-line EGFR-TKIs treatment

  • Original Article – Clinical Oncology

Yang Ni, Xin Ye, Xia Yang, Guanghui Huang, Wenhong Li, Jiao Wang, Xiaoying Han, Zhigang Wei, Min Meng

Precision oncotherapy based on liquid biopsies in multidisciplinary treatment of unresectable recurrent rectal cancer: a retrospective cohort study

  • Open Access
  • Original Article – Clinical Oncology

Stefano Guadagni, Giammaria Fiorentini, Michele De Simone, Francesco Masedu, Odisseas Zoras, Andrew Reay Mackay, Donatella Sarti, Ioannis Papasotiriou, Panagiotis Apostolou, Marco Catarci, Marco Clementi, Enrico Ricevuto, Gemma Bruera

Postoperative biochemical recurrence of pathologically localized high-grade prostate cancer in adjuvant treatment-naïve patients

  • Original Article – Clinical Oncology

Ji Eun Heo, Jee Soo Park, Jong Soo Lee, Jongchan Kim, Won Sik Jang, Nam Hoon Cho, Koon Ho Rha, Young Deuk Choi, Sung Joon Hong, Won Sik Ham

Safety and efficacy of CT-guided radioactive iodine-125 seed implantation assisted by a 3D printing template for the treatment of thoracic malignancies

  • Original Article – Clinical Oncology

Zhe Ji, Yuliang Jiang, Fuxin Guo, Ran Peng, Haitao Sun, Jinghong Fan, Fei Xu, Junjie Wang

18F-FDG PET/CT versus CT/MR imaging for detection of neck lymph node metastasis in palpably node-negative oral cavity cancer

  • Original Article – Clinical Oncology

Mi Rye Bae, Jong-Lyel Roh, Jae Seung Kim, Jeong Hyun Lee, Kyung-Ja Cho, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kim

Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse

  • Original Article – Clinical Oncology

Chinmayee Sethy, Kunal Goutam, Deepika Nayak, Rajalaxmi Pradhan, Sefinew Molla, Subhajit Chatterjee, Niranjan Rout, Michael D. Wyatt, Satya Narayan, Chanakya Nath Kundu

Effects of single-nucleotide polymorphisms in the mTORC1 pathway on the risk of brain metastasis in patients with non-small cell lung cancer

  • Open Access
  • Original Article – Clinical Oncology

Yiquan Xu, Yina Huang, Lihong Weng, Jiankun Zheng, Yi Huang, Ying Lin, Yunan Zhao, Hongru Li, Yusheng Chen

A prospective observational study on the optimal maintenance strategy in HER2-positive advanced gastric cancer treated with trastuzumab-based therapy

  • Original Article – Clinical Oncology

Qian Li, Minzhi Lv, Huiqin Jiang, Yan Wang, Shan Yu, Wei Li, Yiyi Yu, Tianshu Liu

Neu im Fachgebiet Onkologie

Wird die Therapie bei inflammatorischem Brustkrebs voreilig deeskaliert?

Die Prognose beim inflammatorischen Mammakarzinom bleibt ungünstig, wie eine Analyse von US-Registerdaten nahelegt. Ein weiteres Problem ist demnach, dass zunehmend weniger Frauen die leitliniengerechte trimodale Therapie erhalten. 

Fokale Salvage-Therapie bei lokalem Prostatakrebsrezidiv langfristig wirksam

Bei einem nach Radiotherapie lokal rezidivierten Prostatakarzinom sind fokale Salvage-Therapien mit einer guten Prognose verbunden: Das krebsspezifische Zehn-Jahres-Überleben ist einem retrospektiven Vergleich zufolge ebenso hoch wie nach Salvage-Prostatektomie.

Relacorilant verlängert Überleben bei platinresistentem Ovarialkarzinom

Durch Hinzunahme des Glukokortikoid-Rezeptor-Antagonisten Relacorilant zu nab-Paclitaxel wird bei Frauen mit platinresistentem Ovarialkarzinom nicht nur das progressionsfreie, sondern auch das Gesamtüberleben verlängert. Laut finaler Analyse der ROSELLA-Studie gewinnen sie vier Monate an Lebenszeit.

ICI-induzierte Dermatitis: Upadacitinib als vielversprechende Therapieoption

Immunvermittelte Hautreaktionen gehören zu den häufigsten Nebenwirkungen von Immun‑Checkpoint‑Inhibitoren. Eine offene Phase‑2‑Studie untersuchte den JAK‑1‑Inhibitor Upadacitinib bei schwerer ICI‑assoziierter Dermatitis. Die Hautsymptome gingen rasch zurück, schwerwiegende therapieassoziierte Nebenwirkungen wurden nicht beobachtet.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Inflammatorisches Mammakarzinom/© Springer Medizin Verlag GmbH, Eine Person kratzt sich am Rücken über der Schulter/© ryanking999 / stock.adobe.com (Symbolbild mit Fotomodell)